Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.80 -0.11 (-0.69%)
As of: Oct 21, 2026 · 11:33 AM EDT

Ascentage Pharma Group International (AAPG) Debt Ratio (2023)

Updated

Analysis

Ascentage Pharma Group International (AAPG) Debt Ratio (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,134.50 Bn 1,103.09 Bn 19.71 Bn 0.39
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 0.24
3 AbbVie 500.82 Bn 473.93 Bn 12.70 Bn 0.52
4 Merck 367.31 Bn 321.69 Bn 12.21 Bn 0.42
5 Novartis Ag 297.77 Bn 261.76 Bn 11.24 Bn 0.08
6 Astrazeneca 261.35 Bn 235.04 Bn 12.86 Bn 0.28
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.59 Bn 164.79 Bn 6.22 Bn 0.53
9 Pfizer 169.39 Bn 116.04 Bn 10.94 Bn 0.31
10 Ascentage Pharma Group International 1.41 Bn 369.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 0.01
API Access

Ascentage Pharma Group International Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=AAPG&period=max&api_key=YOUR_API_KEY